Dyne Therapeutics (NASDAQ: DYN) stock stood apart from its biotech peers on Hump Day, posting a meaty share price gain across ...

Abivax is preparing a regulatory submission in the U.S. in the second half of 2026, provided an ongoing maintenance trial ...

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

Structure stated that, based on the drug's performance, the company aims to advance it into phase 3 clinical trials. The most ...

Mirum Pharmaceuticals is paying $620 million in cash and stock to buy Bluejay Therapeutics and its phase 3-stage hepatitis drug. At the heart of the deal is brelovitug, an immunoglobulin G1 monoclonal ...

Yttrium: This REE is also known as a transition metal. These are particularly good for “ electrical and thermal conductivity ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

HCA Healthcare and CVS Health are firing on all cylinders.

Analyst John Athanasiou from Red Leaf Securities suggests CSL shares are oversold, presenting a buying opportunity in a ...

Capricor Therapeutics (CAPR) stock is the best stock on Wall Street and burning short sellers after upbeat drug data ...

​Allied Gold Corporation (NYSE: AAUC) is one of the Best Up and Coming Canadian Stocks to Buy. On November 27, Allied Gold ...